Cargando…
Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
Autores principales: | Niu, Huanmin, Qian, Lilin, Luo, Yanhai, Wang, Fang, Zheng, Hongbo, Gao, Yanhui, Wang, Hanbo, Hu, Xuelei, Yuan, Huiqing, Lou, Hongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184988/ https://www.ncbi.nlm.nih.gov/pubmed/34099617 http://dx.doi.org/10.1038/s41392-021-00547-x |
Ejemplares similares
-
Inactivation of TFEB and NF-κB by marchantin M alleviates the chemotherapy-driven pro-tumorigenic senescent secretion
por: Niu, Huanmin, et al.
Publicado: (2019) -
Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
BVS, RDN, IABP: The Afghanistan of interventional cardiology trials
por: Mishra, Sundeep
Publicado: (2018) -
Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B‐mediated degradation of BRCA1
por: Wang, Yanyan, et al.
Publicado: (2018) -
Cell killing by lysosomotropic detergents
Publicado: (1983)